Glucose And Sodium Chloride Injection, Solution
Product Images NDC 0338-9799

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Glucose And Sodium Chloride (NDC 0338-9799). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dhcp Letter 1.jpg (Image 01)

A letter from Baxter Healthcare Corporation dated November 21, 2024, informing healthcare professionals about the temporary importation of 0.9% Sodium Chloride Injection and various Glucose Injection solutions from Baxter's Shanghai facility due to drug shortages. It includes a table listing product names, sizes, product codes, carton quantities, and NDC codes for these imported injections. Additional instructions emphasize inspecting bags for leaks or particulate matter before use.*

FDA Label Image

Dhcp Letter 2.jpg (Image 02)

This text panel provides detailed differences between FDA-approved and imported glucose and sodium chloride injection products by Baxter Healthcare Corporation. It highlights compatibility issues with administration systems and adapters, energy content distinctions of glucose forms, and labeling differences. It also mentions product handling and regulatory considerations for the intravenous solution injections.*

FDA Label Image

Dhcp Letter 3.jpg (Image 03)

This image is a text page from a regulatory or informational document regarding FDA-approved 5% Dextrose/0.9% Sodium Chloride Injection and similar imported products. It provides instructions for reporting adverse events, contact information for Baxter Healthcare Corporation, and links to prescribing information for various related injections. The page includes a signature block from a Baxter Healthcare executive and company trademark notes.*

FDA Label Image

Dhcp Letter 4.jpg (Image 04)

A data table comparing FDA-approved and imported 0.9% Sodium Chloride Injection USP products. It details product names, label volumes, label languages, indications, active ingredients, pH and osmolarity, storage conditions, container types, and medication port closures with accompanying photos of port protectors for both products.*

FDA Label Image

Dhcp Letter 5.jpg (Image 05)

A comparison table displaying label images of FDA-approved and imported 0.9% Sodium Chloride Injection USP. It shows the FDA-approved label with detailed text and the imported product label from Shanghai, China, highlighting differences in design, manufacturer information, and labeling elements for 1000 mL containers.*

FDA Label Image

Dhcp Letter 6.jpg (Image 06)

A comparison table showing key differences between FDA-approved 5% Dextrose Injection USP and imported 5% Glucose Injection from Shanghai, China. It covers product names, label volumes, label languages, indications, active ingredients, additional info like pH and osmolarity, caloric content, storage conditions, container types, and medication port closures with images.*

FDA Label Image

Dhcp Letter 7.jpg (Image 07)

A comparative table showing label images of FDA-approved 5% Dextrose Injection USP (1000 mL) from Baxter Healthcare Corporation and an imported 5% Glucose Injection product from Shanghai, China. The table highlights differences in label content, format, and inclusion of NDC numbers and barcodes for the two intravenous injection solutions.*

FDA Label Image

Dhcp Letter 8.jpg (Image 08)

A comparison table detailing key differences between FDA-approved 10% Dextrose Injection USP and an imported 10% Glucose Injection from Shanghai, China. It covers product names, label volumes, label languages, indications, active ingredients, pH values, osmolarity, caloric content, storage conditions, container types, and medication port closure details with small images of the port closures.*

FDA Label Image

Dhcp Letter 9.jpg (Image 09)

A data table comparing label images of FDA-approved 10% Dextrose Injection USP with an imported 10% Glucose Injection from Shanghai, China. It includes detailed label text, volume markings, manufacturer information for Baxter Healthcare, storage instructions, and packaging details for both products.*

FDA Label Image

Dhcp Letter 10.jpg (Image 10)

A comparison table outlining key differences between FDA-approved 5% Dextrose/0.9% Sodium Chloride Injection USP and an imported 5% Glucose/0.9% Sodium Chloride Injection from Shanghai, China. The table details product names, label volume, label language, indications, active ingredients, additional information including pH, osmolarity, caloric content, storage conditions, container types, and differences in administration port closures with accompanying small photos.*

FDA Label Image

Dhcp Letter 11.jpg (Image 11)

A comparison table of label images for FDA-approved 5% Dextrose/0.9% Sodium Chloride Injection USP and an imported 5% Glucose/0.9% Sodium Chloride Injection from Shanghai. It shows the black text layout, including product names, strengths, volumes (1000 mL), label details, and manufacturer information for each product. The imported label includes barcode location and product licensing details.*

FDA Label Image

Spc304us Image 1.jpg (Image 12)

This image shows the package insert for Glucose and Sodium Chloride Injection by Baxter Healthcare Corporation. It includes information on drug name, ingredients, description, indications, strength, dosage and administration, adverse reactions, and contraindications for this intravenous injection solution.*

FDA Label Image

Spc304us Image 2.jpg (Image 13)

Drug information text panel providing detailed instructions for dosage and administration of sodium chloride, including calculations for fluid replacement and various clinical considerations. It also covers precautions including hypersensitivity reactions, hyperosmolality, hypokalemia, hyponatremia, and risks related to electrolyte and water imbalance during intravenous use of glucose and sodium chloride injection.*

FDA Label Image

Spc304us Image 3.jpg (Image 14)

A multi-section text panel providing detailed clinical information about Glucose and Sodium Chloride injection solution. Sections visible cover warnings related to risk of hypoglycemia, hyperglycemia, fluid and electrolyte imbalance, drug interactions, pediatric and geriatric use, overdose, and rapid administration effects. It includes specific cautions, monitoring guidance, and safety considerations for healthcare providers administering this intravenous solution.*

FDA Label Image

Spc304us Image 4.jpg (Image 15)

This image is a text panel containing detailed drug information for Glucose and Sodium Chloride Injection. It includes warnings, general usage instructions, pharmacology, pharmacokinetics, storage guidelines, packaging details, shelf life, regulatory standards, and manufacturer information. The text also covers pregnancy and lactation considerations and executive standards for the product's strength and license numbers.*

FDA Label Image

A6c1064us Representative Carton Label 1 (Image 16)

Label for Glucose and Sodium Chloride Injection, 1000 ml intravenous solution by Baxter Healthcare Corporation. The label states 5% glucose and 0.9% sodium chloride concentrations. It includes instructions to store in an overwrap and inspect the inner bag for leakage. The label shows lot, manufacturing, and expiration fields, and provides manufacturer information with barcode.*

FDA Label Image

A6c1064us Representative Carton Label 2.jpg (Image 17)

Label for Glucose and Sodium Chloride 5% Glucose/0.9% Sodium Chloride Injection, solution for intravenous use in 1000 mL bags packaged in sets of 12. The label includes lot number, expiration date, manufacturing date, and licensing information, with the labeler identified as Baxter Healthcare Corporation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.